Investigating gender differences in Alzheimer's disease

Area of Science:

• Neuroscience
• Endocrinology
• Pathology

Background:

• Alzheimer's disease (AD) is a neurodegenerative disorder marked by amyloid-β plaques, hyperphosphorylated tau, oxidative stress, and neuroinflammation.
• AD exhibits a higher prevalence in females, suggesting a significant role for gender-dependent factors.

Purpose of the Study:

• To investigate gender-based differences in Alzheimer's disease (AD) neuropathogenesis.
• To examine the influence of sex hormones on AD development and cognitive decline.
• To review current therapeutic strategies, including hormone replacement therapy and estrogen receptor beta interventions.

Main Methods:

• Review of existing literature on gender differences in AD.
• Analysis of the roles of NLRP3 inflammasome, Nrf2, and APOE in gender-dependent AD.
• Examination of hormonal impacts on brain metabolism, insulin resistance, and astrocytic activity.

Main Results:

• Female hormone cessation, like 17β-estradiol decline, exacerbates AD pathology and neurotoxicity.
• Gender differences significantly impact AD dementia rates and neuropathogenesis.
• Sex hormones possess anti-AD activities, influencing brain metabolism and neuroinflammation.

Conclusions:

• Understanding gender-specific mechanisms is crucial for developing targeted AD therapies.
• Hormonal replacement and estrogen receptor beta-based therapies show promise for mitigating AD in at-risk populations.
• Gender-based differences in brain metabolism, insulin resistance, and astrocyte function are key to AD pathogenesis.